VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BCYC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BCYCBicycle Therapeutics plc
$4.15$287M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBCYCQuarterly Financials

Bicycle Therapeutics plc (BCYC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bicycle Therapeutics plc (BCYC) quarterly income statement — complete revenue, gross profit & net income history

BCYC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue887K47.95M11.73M2.92M9.98M3.71M2.68M9.36M19.53M5.33M5.35M11.4M4.9M3.19M3.04M4.38M3.86M3.77M4.33M1.78M
Revenue Growth %-91.11%1193.28%338.49%-68.81%-48.91%-30.44%-50%-17.86%298.9%67.38%76.05%160.32%26.84%-15.54%-29.84%145.27%113.5%-2%12.78%13.62%
Cost of Goods Sold00071.03M57.27M56.07M45.65M0000000000000
COGS % of Revenue---2432.5%574.03%1512.19%1705.83%-------------
Gross Profit887K47.95M11.73M-68.11M-47.29M-52.36M-42.97M9.36M19.53M5.33M5.35M11.4M4.9M3.19M3.04M4.38M3.86M3.77M4.33M1.78M
Gross Margin %100%100%100%-2332.5%-474.03%-1412.19%-1605.83%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %101.88%191.58%127.31%-827.58%-342.16%-1082.25%-902.91%-17.86%298.9%67.38%76.05%160.32%26.84%-15.54%-29.84%145.27%113.5%160.72%12.78%13.62%
Operating Expenses66.48M72.61M77.28M18.49M22.91M15.3M20.87M56.01M51.25M59.57M56.15M54.51M46.7M35.4M32.8M31.68M31.24M21.8M18.63M19.06M
OpEx % of Revenue7494.48%151.42%658.64%633.32%229.63%412.59%780.04%598.31%262.4%1117.35%1049.12%478.27%953.82%1111.33%1078.91%723.57%809.4%577.96%429.89%1067.9%
Selling, General & Admin17.57M20.84M19.02M19.24M20.92M21.02M18.26M16.05M16.45M15.05M15.57M15.18M14.04M10.71M10.25M11.14M16.85M8.72M8.27M7.35M
SG&A % of Revenue1981.4%43.46%162.07%658.84%209.72%566.91%682.25%171.46%84.24%282.35%290.86%133.18%286.66%336.42%337.07%254.55%436.42%231.29%190.81%411.54%
Research & Development48.9M51.77M58.43M71.03M59.06M49.78M48.27M40.06M34.86M44.7M39.87M39.72M32.21M24.72M22.75M19.85M14.28M12.96M10.51M11.72M
R&D % of Revenue5513.08%107.96%497.92%2432.5%591.94%1342.45%1803.62%427.94%178.52%838.44%744.92%348.51%657.9%776.11%748.42%453.49%370.05%343.57%242.63%656.69%
Other Operating Expenses00-158K-1000K-1000K-1000K-1000K-101K-71K-183K714K-390K453K-38K-200K680K113K117K-154K-6K
Operating Income-65.59M-24.66M-65.55M-86.6M-70.2M-67.66M-63.85M-46.65M-31.72M-54.23M-50.8M-43.11M-41.8M-32.21M-29.76M-27.3M-27.38M-18.02M-14.29M-17.28M
Operating Margin %-7394.48%-51.42%-558.64%-2965.82%-703.66%-1824.78%-2385.87%-498.31%-162.4%-1017.35%-949.12%-378.27%-853.82%-1011.33%-978.91%-623.57%-709.4%-477.96%-329.89%-967.9%
Operating Income Growth %6.57%63.56%-2.67%-85.65%-121.35%-24.76%-25.69%-8.2%24.13%-68.37%-70.69%-57.92%-52.66%-78.71%-108.19%-58.01%-70.89%-5.65%-33.9%-37.3%
EBITDA-64.46M-23.32M-63.8M-84.91M-78.52M-65.96M-61.65M-45.01M-30.06M-52.58M-49.11M-41.47M-40.25M-30.82M-28.5M-26.68M-26.96M-17.62M-13.96M-16.94M
EBITDA Margin %-7267.19%-48.63%-543.68%-2907.74%-786.97%-1778.83%-2303.88%-480.79%-153.91%-986.33%-917.54%-363.83%-822.02%-967.82%-937.34%-609.48%-698.47%-467.17%-322.11%-948.85%
EBITDA Growth %17.9%64.64%-3.48%-88.65%-161.22%-25.44%-25.55%-8.54%25.31%-70.58%-72.34%-55.4%-49.27%-74.97%-104.16%-57.54%-71.74%-5.32%-34.9%-38%
D&A (Non-Cash Add-back)1.13M1.34M1.76M1.7M-8.31M1.7M2.19M1.64M1.66M1.65M1.69M1.65M1.56M1.39M1.26M617K422K407K337K340K
EBIT-60.6M-18.83M-58.85M-79.13M-61.89M-67.66M-63.4M-38.87M-26.09M-47.96M-46.81M-42.3M-38.87M-29.57M-27.77M-26.39M-27.16M-17.96M-14.27M-17.25M
Net Interest Income4.83M5.82M-44K7.42M8.36M10.25M10.55M6.95M4.8M5.46M3.17M-9K2.12M1.81M1.17M25K-600K-761K-799K-796K
Interest Income4.88M5.88M07.47M8.41M10.3M10.58M7.77M5.62M6.28M3.98M812K2.93M2.64M1.99M908K218K58K24K23K
Interest Expense48K57K44K54K51K52K33K824K821K820K814K821K808K826K817K883K818K820K823K819K
Other Income/Expense4.94M5.77M6.66M7.42M8.36M14.71M9.6M6.95M4.8M5.46M3.17M-9K2.12M1.81M1.17M25K-600K-761K-799K-796K
Pretax Income-60.65M-18.89M-58.9M-79.18M-61.84M-52.95M-54.25M-39.7M-26.91M-48.78M-47.63M-43.12M-39.68M-30.4M-28.59M-27.27M-27.98M-18.79M-15.09M-18.07M
Pretax Margin %-6837.99%-39.39%-501.92%-2711.75%-619.84%-1428.03%-2027.28%-424.07%-137.8%-915.01%-889.87%-378.35%-810.5%-954.41%-940.3%-623%-724.95%-498.14%-348.33%-1012.49%
Income Tax172K1.26M205K-231K-1.09M-1.08M-3.45M115K-350K320K2.27M-517K-618K-420K-238K-447K-419K-748K-415K-160K
Effective Tax Rate %-0.28%-6.7%-0.35%0.29%1.76%2.04%6.36%-0.29%1.3%-0.66%-4.77%1.2%1.56%1.38%0.83%1.64%1.5%3.98%2.75%0.89%
Net Income-60.83M-20.15M-59.1M-78.95M-60.75M-51.85M-50.8M-39.81M-26.56M-49.1M-49.9M-42.6M-39.06M-29.98M-28.35M-26.83M-27.56M-18.04M-14.68M-17.91M
Net Margin %-6857.38%-42.03%-503.66%-2703.84%-608.94%-1398.44%-1898.43%-425.3%-136.01%-921.01%-932.32%-373.81%-797.88%-941.22%-932.47%-612.79%-714.09%-478.31%-338.75%-1003.53%
Net Income Growth %-0.12%61.13%-16.33%-98.31%-128.72%-5.61%-1.81%6.55%32%-63.78%-76.03%-58.8%-41.72%-66.2%-93.13%-49.77%-70.24%-3.46%-44.78%-47.86%
Net Income (Continuing)-60.83M-20.15M-59.1M-78.95M-60.75M-51.87M-50.8M-39.81M-26.56M-49.1M-49.9M-42.6M-39.06M-29.98M-28.35M-26.83M-27.56M-18.04M-14.68M-17.91M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.87-0.29-0.85-1.14-0.88-0.74-0.74-0.77-0.62-1.16-1.26-1.41-1.30-1.01-0.96-0.90-0.93-0.63-0.59-0.74
EPS Growth %1.14%60.81%-14.86%-48.05%-41.94%36.21%41.27%45.39%52.31%-14.85%-31.25%-56.67%-39.78%-60.32%-62.71%-21.62%-27.4%24.1%-13.46%-10.45%
EPS (Basic)-0.87-0.29-0.85-1.14-0.88-0.74-0.74-0.77-0.62-1.16-1.26-1.41-1.30-1.01-0.96-0.90-0.93-0.63-0.59-0.74
Diluted Shares Outstanding69.68M69.36M69.3M69.25M69.2M69.05M68.99M51.99M42.56M42.42M39.58M30.19M30M29.71M29.68M29.65M29.61M28.79M25.04M24.05M
Basic Shares Outstanding69.68M69.36M69.3M69.25M69.2M69.05M68.99M51.99M42.56M42.42M39.58M30.19M30M29.71M29.68M29.65M29.61M28.79M25.04M24.05M
Dividend Payout Ratio--------------------